Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBabcock Regulatory News (BAB)

Share Price Information for Babcock (BAB)

Share Price is delayed by 15 minutes
Get Live Data
1,035.00    -3.50 (-0.34%)
Bid:
1,036.50
Ask:
1,037.00
Spread: 0.50 (0.048%)
Market Cap: £5.06b
BAB Live PriceLast checked at - London Stock Exchange

Intraday Babcock Share Chart

Trading update

15 Jan 2021 07:00

RNS Number : 7819L
Babcock International Group PLC
15 January 2021
 

15 January 2021 

Babcock International Group PLC (Babcock or the Group)

Trading update

 

Babcock, the aerospace and defence company, issues the following trading update for the first nine months of the financial year ending 31 March 2021.

 

Group trading

Trading in the third quarter saw a continuation of trends in the first half of the year, with weakness in our civil aviation businesses and a negative impact from COVID-19.

 

Underlying revenue in the nine months year to date (YTD) was £3,399 million (9M 2020: £3,574 million), down 3% on last year excluding disposals and FX. Underlying operating profit in the nine months YTD was £202 million (9M 2020: £320 million), down 34% excluding disposals and FX, with a negative impact from civil nuclear insourcing, COVID-19 and civil aviation.

 

Order intake YTD was £3.1 billion with the Group's order book standing at £16.8 billion at 31 December 2020 (31 March 2020: £17.6 billion).

 

Balance sheet

The Group's net debt1 (excluding lease obligations) at 31 December 2020 was £1,207 million, a reduction of £255 million compared to 31 December 20192. Although this position is higher than that reported at 30 September 2020 of £871 million, it is consistent with the average net debt for the first nine months of this financial year of £1,222 million3.

 

Review of contract profitability and balance sheet

We have recently started a detailed review of our balance sheet and contract profitability. Early indications suggest that there may be negative impacts on the balance sheet and/or income statement for current and/or future years. This review is being supported by an independent accounting firm and the outputs will be reviewed by our auditor (PWC), Audit Committee and Board prior to the publication of our audited results for the year ending 31 March 2021 expected in May.

 

Outlook

Uncertainty remains around the outturn for this financial year, especially given that our fourth quarter is historically our strongest and that the COVID-19 situation has worsened in most of our markets. Given this uncertainty, and the start of our review of contract profitability and balance sheet, we continue not to provide financial guidance for this financial year.

 

Review of strategic priorities

We announced a review of the Group's strategic priorities in November 2020 and this is now well underway. Our focus throughout this review will be on cash delivery, being a strategic partner to the UK Government, international growth, driving innovation across the Group, and transforming our ESG and people agenda. We will outline our refreshed strategy alongside our full year results.

 

David Lockwood, CEO said:

"While trading in the third quarter has continued to reflect the challenges of the first half and there remain a number of near term uncertainties, the fundamental strengths of the Group and the opportunities ahead give us confidence for future years and I look forward to reporting back at the full year results".

 

 

For further information please contact:

 

Babcock International Group PLC

Simon McGough Kate Hill

Director of Investor Relations Group Director of Communications

Tel: +44 (0)7850 978 741 Tel: +44 (0)20 7355 5312

 

FTI Consulting

John Waples / Nick Hasell / Alex Le May

Tel: +44 (0)20 3727 1340

 

 

Notes

1. Net debt includes the benefit of ongoing receivables factoring and supply chain finance programmes.

2. This includes net proceeds from the sales of Context, Holdfast and Conbras of £194 million.

3. Based on the average of nine month end positions.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSFSEELEFSEFF
Date   Source Headline
6th Nov 20154:00 pmRNSHolding(s) in Company
23rd Oct 201511:17 amRNSHolding(s) in Company
19th Oct 20152:17 pmRNSDirectorate Change
12th Oct 201510:00 amRNSDefence & Security Division: Contract Update
23rd Sep 20158:00 amRNSDirectorate Changes
18th Sep 20154:59 pmRNSPublication of Base Prospectus
17th Aug 20159:20 amRNSDirector/PDMR Shareholding
3rd Aug 201510:30 amRNSHolding(s) in Company
31st Jul 201511:31 amRNSDirector/PDMR Shareholding
31st Jul 201510:04 amRNSDirector/PDMR Shareholding
30th Jul 20154:24 pmRNSResult of AGM
30th Jul 20158:57 amRNSHolding(s) in Company
30th Jul 20157:00 amRNSAnnual General Meeting Trading Update
17th Jul 201511:29 amRNSDirector/PDMR Shareholding
14th Jul 20153:07 pmRNSHolding(s) in Company
10th Jul 201511:50 amRNSHolding(s) in Company
17th Jun 20154:58 pmRNSAnnual Financial Report
17th Jun 20154:38 pmRNSDirector/PDMR Shareholding
12th Jun 20153:25 pmRNSHolding(s) in Company
12th Jun 201510:06 amRNSDirector/PDMR Shareholding
10th Jun 20159:36 amRNSHolding(s) in Company
3rd Jun 20152:59 pmRNSHolding(s) in Company
3rd Jun 201510:23 amRNSTotal Voting Rights
1st Jun 20153:32 pmRNSNew Listing
18th May 201511:11 amRNSEurope midday: Stocks waver in a tight range; eyes still on Greece
18th May 20157:00 amRNSFinal Results
1st Apr 20154:48 pmRNSHolding(s) in Company
30th Mar 20157:00 amRNSCapital markets seminar and trading update
3rd Mar 201510:30 amRNSAppointment of non executive director
10th Feb 20157:00 amRNSInterim Management Statement
30th Jan 201510:42 amRNSDirector/PDMR Shareholding
20th Jan 201510:00 amRNSCavendish Nuclear contract award
15th Jan 20154:51 pmRNSDirector/PDMR Shareholding
18th Dec 201412:15 pmRNSRelease of Guarantors
17th Dec 20147:00 amRNSAcquisition
20th Nov 20147:00 amRNSHalf Yearly Report
19th Nov 201412:49 pmRNSPreferred Bidder - Defence Support Group
17th Nov 20147:15 amRNSDirector Declaration
10th Oct 201410:16 amRNSHolding(s) in Company
9th Oct 20144:01 pmRNSBlocklisting Interim Review
8th Oct 20149:43 amRNSHolding(s) in Company
3rd Oct 20147:00 amRNSCavendish Nuclear Site Visit
2nd Oct 20145:03 pmRNSPublication of Final Terms
1st Oct 20147:00 amRNSSignature of MSDF
22nd Sep 20145:44 pmRNSPublication of Base Prospectus and Rating
9th Sep 20141:58 pmRNSHolding(s) in Company
1st Sep 201410:01 amRNSContract Signature
20th Aug 20149:27 amRNSDirector/PDMR Shareholding
19th Aug 20143:20 pmRNSDirector/PDMR Shareholding
12th Aug 20143:38 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.